The Impact of Tariffs on Patient Access to Medical Technology
Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.
2024 Annual Report
Explore AdvaMed®’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.
AdvaMed® Advancements: Q4 2024 Report
AdvaMed® is proud to showcase the significant achievements we accomplished in Q4 of 2024.
EY 18th annual Pulse of the MedTech Industry Report
The 18th annual Pulse of the MedTech Industry report finds the medical technology industry continuing to push at new frontiers, as ongoing breakthroughs in MedTech AI and renewed hope for…
AdvaMed® Advancements: Q3 2024 Report
AdvaMed® Advancements: Q3 2024 Report is proud to showcase the significant achievements we accomplished in Q3 of 2024.
Dark Money: Undisclosed Third Party Litigation Funding and Its Impact on Medical Technology
Third party litigation funding has become widespread in the civil justice system. The growing use of TPLF to generate mass tort litigation, particularly against manufacturers of medical technology, misuses the…
Medicare Policy at the Crossroads: Addressing Artificial Intelligence and Software
Medicare beneficiaries stand to gain greatly from the ethical development and use of artificial intelligence (AI) and software solutions that improve the diagnosis and treatment of illness and disability, promote…
Medicare Coverage Processes: An Analysis of Procedural and Resource Concerns
This report focuses on coverage for devices and issues related to procedural delays, the lack of transparency in Medicare’s National Coverage Determination process, the use of Coverage with Evidence Development,…
Future of Medtech: Define New Markets Before They Define You
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.